Asset 2 Conferences

4th Ghent Gut Inflammation Group Meeting

9-10 February 2023, Ghent, Belgium
GGIG23 - Campaign image

4th Ghent Gut Inflammation Group Meeting

4th Ghent Gut Inflammation Group Meeting
Keep me postedAdd to calendar

The ‘Ghent Gut Inflammation Group’ represents a consortium of research labs at Ghent University studying diverse aspects of gastrointestinal biology during health and disease. Understanding how the complex interactions between the intestinal microbiota and host immune as well as stromal cells affect both intestinal and extra-intestinal health (e.g. in the brain and the joints) demands a multi-disciplinary approach. For taking on this challenge, the GGIG consortium connects expertise from 4 different UGent Faculties.

Biennially, GGIG organizes a symposium covering various aspects of intestinal biology in health and disease. The two-day symposium is specifically inviting junior scientists to present their recent work, to promote interaction and collaboration amongst young scientists, and to establish a vibrant network of young scientists studying intestinal mucosal immunology. Although the speakers are junior scientists, the symposium is open to scientists of all levels.

More information on GGIG and previous symposia on www.GGIG.be.

Share

Confirmed speakers

Timon Adolph
Adolph Timon - Profile picture - VIB Conferences
Timon Adolph

Timon Adolph

Medical University of Innsbruck, Department of Gastroenterology & Hepatology, Innsbruck, AT
David Berry
Berry David - profile picture
David Berry

David Berry

Department of Microbiology and Ecosystem Science, University of Vienna, AT
Jens Puschhof
Puschhof Jens - Profile picture - Vib Conferences
Jens Puschhof

Jens Puschhof

Epithelium Microenvironment Interaction Laboratory, Microbiome and Cancer Division, German Cancer Research Center, DE
Jakob Zimmerman
Zimmerman Jakob - Profile picture - VIB Conferences
Jakob Zimmerman

Jakob Zimmerman

Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, CH

Program

Day 1 - Thursday, 09 February, 2023

09:00
09:30
Registration - Coffee
09:30
11:45
Session 1: Mucosal immunology
09:30
10:00
Phenotyping intestinal immune cells in a model of monogenic inflammatory bowel disease

Madeleine Müller Foxworth

Institute for Molecular Immunology and Experimental Oncology Klinikum rechts der Isar, Munich - Technical University Munich, DE
10:00
10:30
Somatic evolution in Inflammatory bowel disease
10:30
11:00
An intercrypt subpopulation of goblet cells is essential for colonic mucus barrier function

Elisabeth Nyström

Institute of Biochemistry, University of Kiel, GE/ Institute of Biomedicine, University of Gothenburg, SE
11:00
11:15
Characterization of Antigen Specific CD4 T Cells Response in Neonatal GALT

Shahed Al Bounny

RWTH University Hospital, Institute for Medical Microbiology, DE
Selected from abstracts
11:15
11:30
Inflammatory monocytes promote pathological fibroblasts activation in Crohn’s Disease

Francesca Biscu

KULeuven, BE
Selected from abstracts
11:30
11:45
The dietary ligand luteolin reduces macrophage inflammatory response and colitis via TRPM8

Donatella Cicia

Univeristy of Naples, IT - KULeuven, BE
Selected from abstracts
11:45
12:00
Unlocking the potential of the human gut microbiome to develop effective and safe therapeutics

Iris Pinheiro

MRM Health, BE
Sponsored talk
12:00
13:00
Lunch Break
13:00
15:00
Session 2: Omics and emerging technologies for gut research
13:00
13:30
Disentangling microbial interactions with colorectal cancer using organoids and organs-on-chips

Jens Puschhof

Epithelium Microenvironment Interaction Laboratory, Microbiome and Cancer Division, German Cancer Research Center, DE
13:30
14:00
Immunocompetent intestinal organoid models to dissect drug-induced inflammation and Inflammatory Bowel Disease
14:00
14:15
Adherent invasive Escherichia coli CCR20 promotes colorectal cancer progression through epithelial adhesion

Maude Jans

UGent, BE
Selected from abstracts
14:15
14:30
TNFΔARE pigs: a physiologically relevant model of Crohn’s Disease for translational research

Thomas Winogrodzki

TUM, DE
Selected from abstracts
14:30
15:00
Coffee Break
15:00
15:30
Session 3: host-microbiota interactions (Part 1)
15:00
15:30
Microbiota influence on immune checkpoint therapy
15:30
16:00
PUFA-induced metabolic changes

Timon Adolph

Medical University of Innsbruck, Department of Gastroenterology & Hepatology, Innsbruck, AT
16:00
16:15
Death, dysbiosis, and disease: How epithelial apoptosis shapes host microbe communication

Christopher Anderson

UGent, BE
Selected from abstracts
16:15
16:30
Direct induction of TGF-β signaling by the intestinal gut microbiota bacterium Anaeroplasma reveals new potential anti-inflammatory probiotic

Victoria von Goetze

Deutsches Rheuma-Forschungszentrum Berlin, DE - Technische Universität Berlin, DE
Selected from abstracts
16:30
18:30
Reception & Poster session

Day 2 - Friday, 10 February, 2023

09:00
09:30
Coffee
09:30
11:30
Session 3: (host-)microbiome (Part 2)
09:30
10:00
Precision medicine and microbiome-based treatments in IBD

Lukas F. Mager

M3 Institute & Department Internal Medicine I, University of Tübingen, DE
10:00
10:30
Tryptophan metabolism in Host-microbiota interactions
10:30
10:45
Paneth cell injury during TNF-induced SIRS: a gateway for bacterial translocation?

Charlotte Wallaeys

UGent, BE
Selected from abstracts
10:45
10:55
The role of galectins in shaping the mucosal immune system of the newborn infant

Saskia Overbeek

Danone Nutricia Research, NL
Sponsored talk
10:55
11:30
Coffee Break
Keynote Lecture
11:30
12:45
Microbiota influence on the gut-brain axis
12:45
13:45
Lunch Break & Poster session
13:45
15:15
Session 4: Microbiota technology and vaccines
13:45
14:15
Noninvasive assessment of gut function using transcriptional recording sentinel cells

Jakob Zimmerman

Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, CH
14:15
14:45
Using single-cell activity-based sorting to identify and isolate microbes with specific physiologies from microbiomes

David Berry

Department of Microbiology and Ecosystem Science, University of Vienna, AT
14:45
15:00
Single cell-based bacterial phenotyping for microbiota-based diagnosis and monitoring of inflammatory bowel diseases and identification of disease-relevant bacteria

Lisa Budzinski

German Rheumatism Research Center; Technische Universität Berlin, DE
Selected from abstracts
15:00
15:15
Integrated Gut Metabolome and Microbiome Fingerprinting Reveals that Dysbiosis Precedes Allergic Inflammation in IgE-Mediated Pediatric Cow’s Milk Allergy

Ellen De Paepe

UGent, BE
Selected from abstracts
15:15
15:30
Closing words + Poster & Presentation prize announcements

Organizing committee

Lars Vereecke

Lars Vereecke

VIB-UGent Center for Inflammation Research, Department of Internal Medicine and Pediatrics, Rheumatology, Ghent University, BE
Debby Laukens

Debby Laukens

VIB-UGent Center for Inflammation Research, intestinal barrier signaling in disease and therapy unit, Faculty of Medicine and Health Sciences, Ghent University, BE

Annemieke Smet

Laboratory of Experimental Medicine and Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, BE

Abstracts

The full list of abstracts will be available on 01-02-2023 until 10-05-2023
This list will only be available for registered attendees of the event.

Attendees

The full list of attendees will be available on 01-02-2023 until 10-05-2023
This list will only be available for registered attendees of the event.